Example: stock market

Pharmacologic Glycemic Management of Type 2 Diabetes in ...

Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial evaluated CV outcomes in 9,340 participants with type 2 diabetes, of whom, 81% had established CVD or stage 3 or higher CKD and 72% had CVD only (6). Over a median follow up of 3.8 years, liraglutide was associated with a significantly lower incidence of MACE than placebo ...

Tags:

  Cardiovascular, Diabetes, Of cardiovascular

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Pharmacologic Glycemic Management of Type 2 Diabetes in ...

Related search queries